Stockholder notice: robbins llp informs stockholders of the revance therapeutics, inc. class action lawsuit

San diego , jan. 7, 2025 /prnewswire/ -- robbins llp informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired revance therapeutics, inc. (nasdaq: rvnc) securities between february 29, 2024 and december 6, 2024. revance is a biotechnology company that develops, manufactures, and commercializes neuromodulators for various aesthetic and therapeutic indications in the u.s. and internationally.
RVNC Ratings Summary
RVNC Quant Ranking